Article Detail - JE Part B
MolDX Local Coverage Determination (LCD) Finalized - Effective October 12, 2026
Date Posted: August 27, 2026
The MolDX Local Coverage Determination (LCD) have completed the Open Public Meeting comment period and are now finalized under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).
| Medicare Coverage Database Number | MolDX LCD Title |
|---|---|
| L40242 | MolDX: Genetic Testing for Hereditary Thrombophilia |
| L40222 | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer |
| Medicare Coverage Database Number | MolDX Billing and Coding Article Title |
|---|---|
| A60272 | Billing and Coding: MolDX: Genetic Testing for Hereditary Thrombophilia |
| A60239 | Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer |
| Medicare Coverage Database Number | Response to Comments |
|---|---|
| A60468 | Response to Comments: MolDX: Genetic Testing for Hereditary Thrombophilia |
| A60509 | Response to Comments: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer |
Effective Date: October 12, 2026
View Active MolDX LCDs on our website or the CMS MCD.
Last Updated Aug 27 , 2026
